An increase in chronic diseases, growing demand for tailored therapies and converging technologies in pharma, nutrition and materials form the rationale behind the selection of this Emerging Business Area.

Biomedical portfolio

Dyneema Purity® – a first example in this field – is a specially developed, high-performance polyethylene fiber, made available to the medical device industry for use in surgical implants. DSM’s current biomedical portfolio also includes hydrophilic coating technology for catheters, guidewires and stent delivery systems.

Target areas
Target areas for future innovation are materials and systems for the musculoskeletal and vascular systems and drug delivery devices in musculoskeletal, vascular and ophthalmic application areas.